- Home
- NSSC vs VERA Comparison
NSSC vs VERA Comparison
Compare NSSC & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSSC
- VERA
- Stock Information
- Founded
- NSSC 1969
- VERA 2016
- Country
- NSSC United States
- VERA United States
- Employees
- NSSC 1070
- VERA N/A
- Industry
- NSSC Telecommunications Equipment
- VERA Biotechnology: Pharmaceutical Preparations
- Sector
- NSSC Telecommunications
- VERA Health Care
- Exchange
- NSSC Nasdaq
- VERA Nasdaq
- Market Cap
- NSSC 1.5B
- VERA 2.5B
- IPO Year
- NSSC N/A
- VERA 2021
- Fundamental
- Price
- NSSC $39.12
- VERA $42.01
- Analyst Decision
- NSSC Strong Buy
- VERA Strong Buy
- Analyst Count
- NSSC 6
- VERA 9
- Target Price
- NSSC $55.33
- VERA $53.56
- AVG Volume (30 Days)
- NSSC 350.1K
- VERA 683.6K
- Earning Date
- NSSC 11-04-2024
- VERA 11-07-2024
- Dividend Yield
- NSSC 1.27%
- VERA N/A
- EPS Growth
- NSSC 83.56
- VERA N/A
- EPS
- NSSC 1.34
- VERA N/A
- Revenue
- NSSC $188,820,000.00
- VERA N/A
- Revenue This Year
- NSSC $14.19
- VERA N/A
- Revenue Next Year
- NSSC $14.67
- VERA N/A
- P/E Ratio
- NSSC $29.43
- VERA N/A
- Revenue Growth
- NSSC 11.07
- VERA N/A
- 52 Week Low
- NSSC $17.76
- VERA $9.68
- 52 Week High
- NSSC $58.09
- VERA $50.78
- Technical
- Relative Strength Index (RSI)
- NSSC 45.46
- VERA 52.57
- Support Level
- NSSC $38.53
- VERA $39.22
- Resistance Level
- NSSC $39.64
- VERA $50.00
- Average True Range (ATR)
- NSSC 1.11
- VERA 2.41
- MACD
- NSSC 0.03
- VERA 0.24
- Stochastic Oscillator
- NSSC 35.31
- VERA 28.53
About NSSC NAPCO Security Technologies Inc.
NAPCO Security Technologies Inc manufactures security products, encompassing access control systems, door-locking products, intrusion and fire alarm systems and video surveillance products. Its products are used for various applications which includes alarm systems like automatic communicators, combination control panels/digital communicators and digital keypad systems, fire alarm control panel and area detectors mainly used for commercial, residential, institutional, industrial and governmental uses.
About VERA Vera Therapeutics Inc.
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.